Biotechnology Product Manufacturing
Description
Brief Excerpt from Industry Overview Chapter:
Companies in this industry manufacture vaccines, toxoids, blood fractions, and culture media of plant or animal origin. Major companies include Amgen, Biogen, Genentech, and Gilead Sciences (all based in the US), as well as Bayer and Merck Group (both based in Germany), CSL (Australia), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France).The global biotechnology market is projected to reach about $5 trillion by 2034, at a compound annual growth rate (CAGR) of nearly 14% from 2025-2034, according to Precedence Research. The top region for biotechnology is the US, followed by China, according to Statista. Other markets include Denmark, the Netherlands, South Korea, the UK, Switzerland, and Taiwan, among others.
The US biotechnology product manufacturing industry generates annual revenue of about $30 billion and has about 350 establishments in the US. Because many drugs are now developed using biotechnology, the biotechnology and pharmaceutical industries overlap considerably. A separate industry report covers Pharmaceutical Manufacturing.
Table of Contents
- Industry Overview
- Quarterly Industry Update
- Business Challenges
- Business Trends
- Industry Opportunities
- Call Preparation Questions
- Financial Information
- Industry Forecast
- Web Links and Acronyms
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



